These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 8531962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
    Yoshioka K, Ito H, Watanabe K, Yano M, Ishigami M, Mizutani T, Sasaki Y, Goto H.
    J Viral Hepat; 2005 Mar; 12(2):139-45. PubMed ID: 15720528
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Association between NS5A gene sequence and response to interferon therapy in chronic hepatitis C patients in Shanghai].
    Hu Y, Tang M, Jiang W, Wu Y, Yuan Z, Wen Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):114-8. PubMed ID: 12196819
    [Abstract] [Full Text] [Related]

  • 9. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J, Czibula A, Simon J, Kalmár T.
    Orv Hetil; 2003 Jun 15; 144(24):1179-84. PubMed ID: 12866147
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V.
    Hepatology; 1995 Oct 15; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the nonstructural protein 5A gene and response to interferon therapy in young patients with chronic hepatitis C virus 1b infection.
    Komatsu H, Fujisawa T, Inui A, Miyagawa Y, Onoue M.
    J Med Virol; 1997 Dec 15; 53(4):361-5. PubMed ID: 9407384
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M.
    J Med Virol; 1996 Apr 15; 48(4):354-9. PubMed ID: 8699168
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T, Enomoto N, Marumo F, Sato C.
    Hepatology; 1998 Oct 15; 28(4):1147-53. PubMed ID: 9755255
    [Abstract] [Full Text] [Related]

  • 16. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.
    Kobayashi M, Watanabe K, Ishigami M, Murase K, Ito H, Ukai K, Yano M, Takagi K, Hattori M, Kakumu S, Yoshioka K.
    Am J Gastroenterol; 2002 Apr 15; 97(4):988-98. PubMed ID: 12003437
    [Abstract] [Full Text] [Related]

  • 17. Mutations in interferon sensitivity-determining region of hepatitis C virus: its relation to change in viral load.
    Terazawa Y, Yoshioka K, Kobayashi M, Watanabe K, Ishigami M, Yano M, Takagi K, Kakumu S.
    Am J Gastroenterol; 2000 Jul 15; 95(7):1781-7. PubMed ID: 10925985
    [Abstract] [Full Text] [Related]

  • 18. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M, Hamada K, Koya S, Arai K, Sokawa Y, Okuno T.
    Hepatology; 1996 Nov 15; 24(5):1018-23. PubMed ID: 8903369
    [Abstract] [Full Text] [Related]

  • 19. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM, Sheen IS, Liaw YF.
    Infection; 2004 Jun 15; 32(3):153-6. PubMed ID: 15188075
    [Abstract] [Full Text] [Related]

  • 20. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence is not a predictive factor for response to interferon-alpha therapy and development of hepatocellular carcinoma.
    Bae SH, Park YM, Yoo DG, Choi JY, Byun BH, Yang JM, Lee CD, Cha SB, Park DH, Kim BS.
    J Korean Med Sci; 2000 Feb 15; 15(1):53-8. PubMed ID: 10719809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.